AU2016341938B2 - Methods of preparing a primary cell sample - Google Patents

Methods of preparing a primary cell sample Download PDF

Info

Publication number
AU2016341938B2
AU2016341938B2 AU2016341938A AU2016341938A AU2016341938B2 AU 2016341938 B2 AU2016341938 B2 AU 2016341938B2 AU 2016341938 A AU2016341938 A AU 2016341938A AU 2016341938 A AU2016341938 A AU 2016341938A AU 2016341938 B2 AU2016341938 B2 AU 2016341938B2
Authority
AU
Australia
Prior art keywords
cell
sample
anoikis
cells
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2016341938A
Other languages
English (en)
Other versions
AU2016341938A1 (en
Inventor
Abhijit Dandapat
Lance Gavin Laing
Ben RICH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celcuity Inc
Original Assignee
Celcuity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celcuity Inc filed Critical Celcuity Inc
Publication of AU2016341938A1 publication Critical patent/AU2016341938A1/en
Assigned to CELCUITY INC. reassignment CELCUITY INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: CELCUITY LLC
Application granted granted Critical
Publication of AU2016341938B2 publication Critical patent/AU2016341938B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/48—Regulators of apoptosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/73—Hydrolases (EC 3.)
    • C12N2501/734—Proteases (EC 3.4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2016341938A 2015-10-20 2016-10-20 Methods of preparing a primary cell sample Ceased AU2016341938B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562243765P 2015-10-20 2015-10-20
US62/243,765 2015-10-20
PCT/US2016/057923 WO2017070353A1 (en) 2015-10-20 2016-10-20 Methods of preparing a primary cell sample

Publications (2)

Publication Number Publication Date
AU2016341938A1 AU2016341938A1 (en) 2018-04-26
AU2016341938B2 true AU2016341938B2 (en) 2022-12-01

Family

ID=57233884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016341938A Ceased AU2016341938B2 (en) 2015-10-20 2016-10-20 Methods of preparing a primary cell sample

Country Status (9)

Country Link
US (2) US11591573B2 (enExample)
EP (1) EP3365436B1 (enExample)
JP (2) JP7202613B2 (enExample)
KR (1) KR102757122B1 (enExample)
CN (1) CN108138146A (enExample)
AU (1) AU2016341938B2 (enExample)
CA (1) CA2999054A1 (enExample)
DK (1) DK3365436T3 (enExample)
WO (1) WO2017070353A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2999054A1 (en) 2015-10-20 2017-04-27 Celcuity Llc Methods of preparing a primary cell sample
CN108300688B (zh) * 2018-02-07 2021-02-02 上海赛立维生物科技有限公司 原代肝细胞分离和培养方法
CN109402051A (zh) * 2018-12-28 2019-03-01 青岛麦迪赛斯生物科技有限公司 一种人脐带间充质干细胞无血清培养基
CN109777736B (zh) * 2019-01-29 2022-03-25 美闺(长沙)医疗美容有限公司 一种活细胞分析设备及方法
CN109943520B (zh) * 2019-03-08 2023-06-23 中国人民解放军军事科学院军事医学研究院 汗腺细胞的分离和培养获得汗腺类器官的方法及其应用
WO2021119056A1 (en) 2019-12-09 2021-06-17 Celcuity Inc. Methods of treating cancer patients with ras node or rtk targeted therapeutic agents
CN111733136B (zh) * 2020-06-29 2021-11-30 中山大学孙逸仙纪念医院 一种提高CD90posi细胞分离效率的方法
JP7452764B2 (ja) 2021-10-27 2024-03-19 住友ベークライト株式会社 ステータ及び構造体

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795897A1 (fr) * 2005-12-12 2007-06-13 Université de Limoges Test prédictif de réponse thérapeutique du cancer du sein
WO2009066258A1 (en) * 2007-11-20 2009-05-28 Hopitaux Universitaires De Geneve Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof
WO2013050962A1 (en) * 2011-10-04 2013-04-11 Mitra Biotech Private Limited Ecm composition, tumor microenvironment platform and methods thereof
WO2014132032A1 (en) * 2013-02-27 2014-09-04 Cancer Research Technology Limited Culture of leukemia initiating cells
US20150125894A1 (en) * 2012-06-12 2015-05-07 Celcuity Llc Whole cell assays and methods
WO2015089380A2 (en) * 2013-12-12 2015-06-18 Celcuity Llc Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018216A1 (en) 1993-12-30 1995-07-06 Nitta Gelatin Inc. Process for embedding culture of animal cells
US5858678A (en) 1994-08-02 1999-01-12 St. Louis University Apoptosis-regulating proteins
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
ATE527341T1 (de) 2004-10-27 2011-10-15 Univ Bruxelles Hepatische differenzierung von stammzellen
US9096827B2 (en) 2008-09-02 2015-08-04 Pluristem Ltd. Adherent cells from placenta tissue and use thereof in therapy
WO2011090068A1 (ja) 2010-01-19 2011-07-28 株式会社Ｒｅｉメディカル 癌組織由来細胞塊または癌細胞凝集塊の培養方法、評価方法および保存方法
CN103025887A (zh) 2010-05-03 2013-04-03 麦克罗斯特姆公司 筛选方法、由其确定的组合物、可用于其确定的工具和由其生产的细胞群
TWI477599B (zh) 2011-01-28 2015-03-21 Hon Hai Prec Ind Co Ltd 培育基體
US20140142000A1 (en) 2012-10-25 2014-05-22 Academia Sinica Microfluidic array platform for simultaneous cell culture under oxygen tensions
CA2895791A1 (en) 2013-01-25 2014-07-31 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
WO2015156929A1 (en) * 2014-04-07 2015-10-15 The Trustees Of Columbia University In The City Of New York Method for culture of human bladder cell lines and organoids and uses thereof
CA2999054A1 (en) * 2015-10-20 2017-04-27 Celcuity Llc Methods of preparing a primary cell sample

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795897A1 (fr) * 2005-12-12 2007-06-13 Université de Limoges Test prédictif de réponse thérapeutique du cancer du sein
WO2009066258A1 (en) * 2007-11-20 2009-05-28 Hopitaux Universitaires De Geneve Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof
WO2013050962A1 (en) * 2011-10-04 2013-04-11 Mitra Biotech Private Limited Ecm composition, tumor microenvironment platform and methods thereof
US20150125894A1 (en) * 2012-06-12 2015-05-07 Celcuity Llc Whole cell assays and methods
WO2014132032A1 (en) * 2013-02-27 2014-09-04 Cancer Research Technology Limited Culture of leukemia initiating cells
WO2015089380A2 (en) * 2013-12-12 2015-06-18 Celcuity Llc Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent

Also Published As

Publication number Publication date
WO2017070353A1 (en) 2017-04-27
US20230235293A1 (en) 2023-07-27
CN108138146A (zh) 2018-06-08
JP7202613B2 (ja) 2023-01-12
JP2021175415A (ja) 2021-11-04
CA2999054A1 (en) 2017-04-27
AU2016341938A1 (en) 2018-04-26
US20180230434A1 (en) 2018-08-16
KR20180057653A (ko) 2018-05-30
DK3365436T3 (da) 2021-10-11
EP3365436A1 (en) 2018-08-29
KR102757122B1 (ko) 2025-01-21
US11591573B2 (en) 2023-02-28
US12215356B2 (en) 2025-02-04
JP2018531021A (ja) 2018-10-25
HK1252635A1 (zh) 2019-05-31
EP3365436B1 (en) 2021-09-08

Similar Documents

Publication Publication Date Title
US12215356B2 (en) Methods of preparing a primary cell sample
Bertolo et al. Autofluorescence is a reliable in vitro marker of cellular senescence in human mesenchymal stromal cells
Arnaoutova et al. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract
JP2018531021A6 (ja) 初代細胞試料を調製する方法
EP3223831B1 (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
Kojima et al. Efficient production of trophoblast lineage cells from human induced pluripotent stem cells
Burt et al. Adriamycin-induced podocyte injury disrupts the YAP-TEAD1 axis and downregulates Cyr61 and CTGF expression
Mikhailova et al. Comparative proteomics reveals human pluripotent stem cell-derived limbal epithelial stem cells are similar to native ocular surface epithelial cells
Lowndes et al. Constructing cellular niche properties by localized presentation of Wnt proteins on synthetic surfaces
Gomes-Alves et al. In vitro expansion of human cardiac progenitor cells: exploring'omics tools for characterization of cell-based allogeneic products
JP2021525100A (ja) 増殖性肝細胞を培養する方法
Chen et al. Cryopreservation and recovery of human endometrial epithelial cells with high viability, purity, and functional fidelity
Patel et al. Effect of physiological oxygen on primary human corneal endothelial cell cultures
US20210208144A1 (en) Mitochondrial protease oma1 as a marker for breast cancer
CN113249328B (zh) EpCAM在调控人肝前体细胞肝向分化中的应用
Cavanaugh et al. Mechanotransductive N-cadherin binding induces differentiation in human neural stem cells
US20220313733A1 (en) Method for producing renal interstitial cell
HK1252635B (en) Methods of preparing a primary cell sample
Idris et al. Establishment of murine in vitro blood-brain barrier models using immortalized cell lines: co-cultures of brain endothelial cells, astrocytes, and neurons
Kato et al. Protocol for gene knockdown using siRNA in primary cultured neonatal murine microglia
CN107142238B (zh) 组蛋白去乙酰化酶抑制剂在细胞培养中的用途及细胞培养基
Yamazaki et al. Reprogramming canine cryopreserved hepatocytes to hepatic progenitor cells using small molecule compounds
Pathak et al. Enhanced post-thaw functional characteristics of cryopreserved caprine dermal fibroblasts through adhesion to extracellular matrix proteins
US20240124835A1 (en) Methods and devices for generating embryos in vitro from embryonic stem cells
Korsgen et al. Analysis of autophagy deficiency and cytotoxicity in autophagy-deficient human embryonic stem cell-derived neurons

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: CELCUITY INC.

Free format text: FORMER NAME(S): CELCUITY LLC

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired